Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary artery disease. 1989

I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
Surgery Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

This study describes the operative management and outcome of 28 patients with obstructive hypertrophic cardiomyopathy and hemodynamically significant coronary artery disease. Each patient underwent coronary artery bypass grafting and concomitant left ventricular myotomy-myectomy or mitral valve replacement. The mean age at operation was 59 years (range 42 to 74). Five patients (18%) died as a result of operation, four in the immediate postoperative period and one at 2 months postoperatively. Three patients died after the immediate postoperative period of causes unrelated to the operation. The mean follow-up period for the 20 currently surviving patients was 4.8 years (range 4 months to 10.8 years). Nineteen of these patients have experienced substantial functional improvement; all are currently asymptomatic or only mildly symptomatic. Twenty-one patients underwent cardiac catheterization before and after operation; each experienced relief of left ventricular outflow tract obstruction after operation. Twelve patients had a preoperative outflow gradient greater than or equal to 50 mm Hg (average 86 +/- 7) under basal conditions, which decreased to 3 +/- 1.8 mm Hg postoperatively (p less than 0.001). Nine patients had a severe preoperative gradient only with a provocative maneuver (average 93 +/- 6 mm Hg), which decreased to 24 +/- 8 mm Hg postoperatively (p less than 0.001). Five of the 24 patients undergoing left ventricular myotomy-myectomy incurred an iatrogenic ventricular septal defect. This operative complication occurred primarily in patients with a relatively thin ventricular septum (less than 20 mm) and contributed importantly to postoperative death in two of the patients.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
August 2006, Journal of cardiothoracic and vascular anesthesia,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
August 2003, Journal of the Formosan Medical Association = Taiwan yi zhi,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
December 1979, Chest,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
January 1996, Indian heart journal,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
January 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
March 2014, BMJ case reports,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
August 1984, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
August 2005, The American journal of cardiology,
I L Siegman, and B J Maron, and L C Permut, and C L McIntosh, and R E Clark
May 1985, The American journal of cardiology,
Copied contents to your clipboard!